SOX2-OT induced by PAI-1 promotes triple-negative breast cancer cells metastasis by sponging miR-942-5p and activating PI3K/Akt signaling

[1]  C. Maher,et al.  Long noncoding RNAs in cancer metastasis , 2021, Nature Reviews Cancer.

[2]  Maite Huarte,et al.  Gene regulation by long non-coding RNAs and its biological functions , 2020, Nature reviews. Molecular cell biology.

[3]  Lei Wang,et al.  Circ_0015756 promotes the progression of ovarian cancer by regulating miR-942-5p/CUL4B pathway , 2020, Cancer cell international.

[4]  B. Győrffy,et al.  Pancancer survival analysis of cancer hallmark genes , 2020, Scientific Reports.

[5]  Siwei Wang,et al.  Long non-coding RNAs in lung cancer: implications for lineage plasticity-mediated TKI resistance , 2020, Cellular and Molecular Life Sciences.

[6]  G. Sethi,et al.  The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential. , 2020, Biochimica et biophysica acta. Reviews on cancer.

[7]  Liang Zhao,et al.  circRNA-AKT1 Sequesters miR-942-5p to Upregulate AKT1 and Promote Cervical Cancer Progression , 2020, Molecular therapy. Nucleic acids.

[8]  Z. Ouyang,et al.  CircRNA hsa_circ_0074834 promotes the osteogenesis-angiogenesis coupling process in bone mesenchymal stem cells (BMSCs) by acting as a ceRNA for miR-942-5p , 2019, Cell Death & Disease.

[9]  H. He,et al.  Landscape of Noncoding RNA in Prostate Cancer. , 2019, Trends in genetics : TIG.

[10]  Yahui Ding,et al.  ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K/AKT pathway in glioma , 2019, Cell Death & Disease.

[11]  J. Xie,et al.  circEPSTI1 regulates ovarian cancer progression via decoying miR‐942 , 2019, Journal of cellular and molecular medicine.

[12]  Xin Hu,et al.  The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation , 2019, Science Advances.

[13]  L. Qin,et al.  Long noncoding RNA SOX2‐OT facilitates laryngeal squamous cell carcinoma development by epigenetically inhibiting PTEN via methyltransferase EZH2 , 2019, IUBMB life.

[14]  S. Yip,et al.  Long non-coding RNAs in hematological malignancies: translating basic techniques into diagnostic and therapeutic strategies , 2018, Journal of Hematology & Oncology.

[15]  J. Xu,et al.  Epithelial-mesenchymal transition induced PAI-1 is associated with prognosis of triple-negative breast cancer patients. , 2018, Gene.

[16]  Yan Shen,et al.  An androgen receptor negatively induced long non-coding RNA ARNILA binding to miR-204 promotes the invasion and metastasis of triple-negative breast cancer , 2018, Cell Death & Differentiation.

[17]  Jinlin Liu,et al.  The prognostic value of long noncoding RNA Sox2ot expression in various cancers: A systematic review and meta-analysis. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[18]  Hui Liu,et al.  Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma , 2018, Oncogene.

[19]  Chad J. Creighton,et al.  UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses , 2017, Neoplasia.

[20]  J. Xu,et al.  PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer , 2017, Scientific Reports.

[21]  J. Balko,et al.  Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease , 2016, Nature Reviews Clinical Oncology.

[22]  J. Xu,et al.  Skp2 is over-expressed in breast cancer and promotes breast cancer cell proliferation , 2016, Cell cycle.

[23]  J. Gustafsson,et al.  BRCA1 inhibits AR–mediated proliferation of breast cancer cells through the activation of SIRT1 , 2016, Scientific Reports.

[24]  Maite Huarte.  The emerging role of lncRNAs in cancer , 2015, Nature Medicine.

[25]  Fang Yang,et al.  BRCA1 regulates PIG3-mediated apoptosis in a p53-dependent manner , 2015, Oncotarget.

[26]  S. Sukumar,et al.  Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis , 2014, Nature Communications.

[27]  A. Gils,et al.  Three Decades of Research on Plasminogen Activator Inhibitor-1: A Multifaceted Serpin , 2013, Seminars in Thrombosis & Hemostasis.

[28]  Howard Y. Chang,et al.  Long Noncoding RNAs: Cellular Address Codes in Development and Disease , 2013, Cell.

[29]  P. Boyle,et al.  Triple-negative breast cancer: epidemiological considerations and recommendations. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[30]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[31]  D. Cacchiarelli,et al.  A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA , 2011, Cell.

[32]  Johan Staaf,et al.  GOBO: Gene Expression-Based Outcome for Breast Cancer Online , 2011, PloS one.

[33]  D. Rickman,et al.  Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays , 2008, Oncogene.

[34]  J. Foidart,et al.  Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis. , 2008, Cancer cell.

[35]  N. Brünner,et al.  Plasminogen activator inhibitor 1 protects fibrosarcoma cells from etoposide-induced apoptosis through activation of the PI3K/Akt cell survival pathway. , 2008, Neoplasia.

[36]  Ross Tubo,et al.  Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.

[37]  Raffaele Fronza,et al.  Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis. , 2006, Carcinogenesis.

[38]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.